83 results
Page 2 of 5
F-3
EX-5.1
u9vrbah2yx80m 7wm
3 May 22
Shelf registration (foreign)
7:25pm
F-3
yk2pzt3w0iff9m tq
3 May 22
Shelf registration (foreign)
7:25pm
424B3
4x6y nyfawa4dnvbr
3 May 22
Prospectus supplement
4:55pm
F-3
EX-5.1
ttmd zdm8n7k
14 Apr 22
Shelf registration (foreign)
9:30pm
F-3
hm7pcrvp 3tcbv
14 Apr 22
Shelf registration (foreign)
9:30pm
424B5
qu3ut0may
19 Aug 21
Prospectus supplement for primary offering
4:13pm
F-3
9hqp 6ox0xz5pmrodnm
6 Aug 21
Shelf registration (foreign)
2:30pm
F-3
EX-4.4
pqc v0fcn
6 Aug 21
Shelf registration (foreign)
2:30pm
F-3
EX-5.1
59kczt makr5ne
6 Aug 21
Shelf registration (foreign)
2:30pm
6-K
18bpdarwprbx2dl9x
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-1
ust88qvdp 9rierd1k
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-1.1
vheftoalyt iaxr3gay4
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K
EX-5.1
ivb89 tx6
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
424B5
6pvw9
11 Feb 21
Prospectus supplement for primary offering
5:16pm
424B5
sxnjwdrql32gu
8 Feb 21
Prospectus supplement for primary offering
5:27pm
6-K
EX-99.2
t0s5byhlkl8ijut
7 Dec 20
Updated data from the ALLCAR study suggests AUTO1’s potential for transformational activity in adult patients with r/r ALL
4:00pm